Literature DB >> 9334169

Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.

G Natoli1, A Costanzo, F Moretti, M Fulco, C Balsano, M Levrero.   

Abstract

Like other members of the tumor necrosis factor (TNF) receptor family, p55 TNF receptor 1 (TNF-R1) lacks intrinsic signaling capacity and transduces signals by recruiting associating molecules. The TNF-R1 associated death domain protein interacts with the p55 TNF-R1 cytoplasmic domain and recruits the Fas-associated death domain protein (which directly activates the apoptotic proteases), the protein kinase receptor interacting protein, and TNF receptor-associated factor 2 (TRAF2). TRAF2 has previously been demonstrated to activate both transcription factor nuclear factor kappaB (NFkappaB) and the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) pathway, which in turn stimulates transcription factor activating protein 1 (AP1) mainly via phosphorylation of the c-Jun component. We have investigated the signaling properties of NFkappaB-inducing kinase (NIK), a TRAF2-associated protein kinase that mediates NFkappaB induction. NIK was found to be unable to activate JNK/SAPK, mitogen-activated protein kinase, or p38 kinase. Moreover, NIK was not required for JNK/SAPK activation by TNF-R1, thus representing the first TNF-R1 complex component to dissect the NFkappaB and the JNK/SAPK pathways. Despite being unable to activate JNK/SAPK and mitogen-activated protein kinase, NIK strongly activated AP1 and was required for TNF-R1-induced AP1 activation. Therefore, NIK links TNF-R1 to a novel, JNK/SAPK-independent, AP1 activation pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334169     DOI: 10.1074/jbc.272.42.26079

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.

Authors:  E Kopp; R Medzhitov; J Carothers; C Xiao; I Douglas; C A Janeway; S Ghosh
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

2.  JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?

Authors:  M Karin; M Delhase
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 3.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

4.  Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways.

Authors:  H Holtmann; R Winzen; P Holland; S Eickemeier; E Hoffmann; D Wallach; N L Malinin; J A Cooper; K Resch; M Kracht
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 5.  Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.

Authors:  B B Aggarwal
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Oral mucosal endotoxin tolerance induction in chronic periodontitis.

Authors:  Manoj Muthukuru; Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1.

Authors:  Megan Brown; Marcia Bellon; Christophe Nicot
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

8.  Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.

Authors:  Christopher J MacKenzie; Andrew Paul; Susan Wilson; Rainer de Martin; Andrew H Baker; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  Induction of proneurotrophins and activation of p75NTR-mediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures.

Authors:  Marta Volosin; Christy Trotter; Andrea Cragnolini; Rajappa S Kenchappa; Matthew Light; Barbara L Hempstead; Bruce D Carter; Wilma J Friedman
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.